Answers are grounded in this paper and cite their sources.
Aza-peptide aldehydes and ketones inhibit the human 20S proteasome in multiple myeloma, suggesting new therapeutic avenues.
Aims Aza-peptide aldehydes and ketones were developed as a new class of peptidyl analogues to inhibit the human constitutive (c)20S proteasome as alternative therapeutics to treat multiple myeloma (MM).
No takes yet. Share an insight, caveat, or question.
Corrigan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: